| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/20/2005 | EP1523504A2 A tissue factor binding immunoconjugate comprising factor viia |
| 04/20/2005 | EP1523372A2 Ghrelin-carrier conjugates |
| 04/20/2005 | EP1523338A1 Steroid conjugates, their preparation and the use thereof |
| 04/20/2005 | EP1523336A1 Targeted agents for nerve regeneration |
| 04/20/2005 | EP1523335A2 Injectable depot formulation comprising crystals of iloperidone |
| 04/20/2005 | EP1523334A2 Hapten-carrier conjugates and uses thereof |
| 04/20/2005 | EP1523326A2 Insulin-associated peptides with effects on cerebral health |
| 04/20/2005 | EP1523325A2 Methods and compositions for treating polycystic ovary syndrome |
| 04/20/2005 | EP1523319A1 Method for sustaining direct cell delivery |
| 04/20/2005 | EP1523307A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 04/20/2005 | EP1523287A2 Materials with both bioadhesive and biodegradable components |
| 04/20/2005 | EP1523239A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
| 04/20/2005 | EP1458355A4 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 04/20/2005 | EP1443921B1 Production of pure stereoisomers of tricyclo-[5.2.1.0(2.6)]-dec-9-yl-xanthate esters and their use as medicaments |
| 04/20/2005 | EP1365737B1 Stable salts of o-acetylsalicyclic with basic amino acids |
| 04/20/2005 | EP1363626A4 Antifungal remedy formulation for external application |
| 04/20/2005 | EP1307263B1 New use of lipase inhibitors |
| 04/20/2005 | EP1240212B1 Crosslinked copolymers based on non-crosslinked polycarboxylic copolymers |
| 04/20/2005 | EP1189926B1 Rapid dehydration of proteins |
| 04/20/2005 | EP1152751B1 Desoxypeganine transdermal therapeutic system |
| 04/20/2005 | EP1135168B1 Peptides carrying substances across the blood brain barrier |
| 04/20/2005 | EP1131057B1 Cushioning wax beads for making solid shaped articles |
| 04/20/2005 | EP1068226B1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 04/20/2005 | EP1059911B1 Formulations with an anti-viral effect |
| 04/20/2005 | EP1047452B1 Conjugates comprising two active agents |
| 04/20/2005 | EP0954278B1 Pharmaceutical compositions containing kukui nut oil |
| 04/20/2005 | EP0949919B1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 04/20/2005 | EP0852488B2 Topical composition containing a silicone-grafted polymer and an amine silicone and/or a silicone gum or resin |
| 04/20/2005 | EP0831886B1 Thrombopoietin compositions |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0766554B1 Polymer microparticles for drug delivery |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/20/2005 | CN1607963A Magnetic nanodispersion comprising cyclodextrines and method for the production thereof |
| 04/20/2005 | CN1607962A Manufacture of polyglutamate-therapeutic agent conjugates |
| 04/20/2005 | CN1607958A Liquid composition of modified factor vii polypeptides |
| 04/20/2005 | CN1607950A A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 04/20/2005 | CN1607948A Composition comprising paracetamol and a bitterness masking component |
| 04/20/2005 | CN1607947A Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol |
| 04/20/2005 | CN1607946A Dermatological/cosmetic gels comprising at least one retinoid and benzoyl peroxide |
| 04/20/2005 | CN1607945A Composite dosage forms with a coating portion |
| 04/20/2005 | CN1607944A Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 04/20/2005 | CN1607943A Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
| 04/20/2005 | CN1607942A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607941A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607940A Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 04/20/2005 | CN1607938A Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 04/20/2005 | CN1607937A Injectable compositions for the controlled delivery of pharmacologically active compound |
| 04/20/2005 | CN1607390A Nanoparticles with polymer shells |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1606985A Beewax essence millimicrosphere preparation and its uses in medicine |
| 04/20/2005 | CN1606920A Oral administration technology of suspended drug bait for curing pearl shell disease |
| 04/20/2005 | CN1197972C Process for producing Lycopen |
| 04/20/2005 | CN1197899C Controlled release polyacrylic acid granules and process for preparing same |
| 04/20/2005 | CN1197846C Carotenoid ester |
| 04/20/2005 | CN1197624C Natural porous polymer beads, the preparation and application thereof |
| 04/20/2005 | CN1197623C Sparagin injection using xylitol as isosmotic adjusting agent |
| 04/20/2005 | CN1197622C Emulsion-type lubricant for medical appliance and its application in medical rubber product |
| 04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 04/20/2005 | CN1197616C Oral peptide pharmaceutical products |
| 04/20/2005 | CN1197578C Pharmaceutical suspension comprising nevirapine hemihydrate |
| 04/20/2005 | CN1197575C Cetirizing hydrochloride cataplasm preparation |
| 04/20/2005 | CN1197574C Method for stabilizing benzimidazole compounds |
| 04/20/2005 | CN1197573C Liniment of levamisole hydrochloride |
| 04/20/2005 | CN1197568C Dihydroarteannuin preparation for controlling broad-spectrum malaria and its preparation method |
| 04/20/2005 | CN1197555C Oral cavity disintegration type solid preparation and method for making same |
| 04/20/2005 | CN1197554C Solid lipid formulations |
| 04/20/2005 | CN1197553C Method of producing vitamin powder |
| 04/20/2005 | CN1197551C Dispersion formulations containing lipase inhibitors |
| 04/20/2005 | CN1197550C Composition set and kit for use in intraocular surgery |
| 04/20/2005 | CN1197541C Two chamber cartridge for atomizers |
| 04/20/2005 | CN1197483C Method of producing oily suspensions of water-soluble vitamins |
| 04/19/2005 | US6881829 Complexing drug with substance p |
| 04/19/2005 | US6881825 Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues |
| 04/19/2005 | US6881822 Antibody for use in the treatment of tumors |
| 04/19/2005 | US6881789 A biopolymer containing a mixture of ubiquitin and at least one cross-linking agent which is selected from photoreactive or thermoreactive crosslinker |
| 04/19/2005 | US6881776 Two-phase gel compositions obtained by mixing a gelled ester, ether, alcohol, natural fats or oils, triblock copolymers, star polymers, radial polymers, multi-block copolymers; and a hydrophobic, nonpolar solvent. |
| 04/19/2005 | US6881766 Sutures and coatings made from therapeutic absorbable glass |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881745 Pharmaceutical compositions for poorly soluble drugs |
| 04/19/2005 | US6881731 Enhancers for microbiological disinfection |
| 04/19/2005 | US6881726 Aqueous compositions containing metronidazole |
| 04/19/2005 | US6881718 Discovery of novel disulfide linked cell toxins which can ablate NK-1 receptor expressing cells. These toxins are used as pharmaceutical compositions for the ablation of NK1 receptor expressing cells and comprise a substance P |
| 04/19/2005 | US6881576 Forming a polyampholyte having a net charge, in the presence of a polyion; and, delivering the complex into a cell |
| 04/19/2005 | US6881449 Low viscosity, hardenable alginates as film forming; spray coating |
| 04/19/2005 | US6881422 Drug for respiratory system disorders |
| 04/19/2005 | US6881421 Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients |
| 04/19/2005 | US6881415 Emulsifier-free finely dispersed water-in-oil type systems |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6880694 Method and apparatus for transferring substrates |
| 04/19/2005 | CA2295035C Pharmaceutical formulations containing voriconazole |
| 04/19/2005 | CA2150462C Syrup containing n-acetyl-cysteine |
| 04/14/2005 | WO2005033181A2 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 04/14/2005 | WO2005033143A1 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 04/14/2005 | WO2005032597A1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/14/2005 | WO2005032594A2 Alkylators linked to polyamides as dna binding agents |
| 04/14/2005 | WO2005032593A1 Polyarginine-modified liposome capable of transferring into nucleus |
| 04/14/2005 | WO2005032592A1 Hypnotic composition |
| 04/14/2005 | WO2005032588A1 Preparation containing basic drug |
| 04/14/2005 | WO2005032557A1 Mycocide composition |
| 04/14/2005 | WO2005032538A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |